Title
Category
Credits
Event date
Cost
Chronic Myeloid Leukemia: How to Treat During Pregnancy
  • Systemic Light Chain Amyloidosis
  • 0.25 AAPA Category 1 CME credit
  • 0.25 ACPE contact hours
  • 0.25 AMA PRA Category 1 Credit™
  • 0.25 ANCC contact hours
  • 0.25 Participation
$0.00
Chronic myeloid leukemia (CML) can affect individuals of reproductive age, and tyrosine kinase inhibitor (TKI) therapy is known to have teratogenic effects. Discontinuing TKI therapy during pregnancy poses a risk of recurrence. Shared decision making is recommended in the management of patients with CML during pregnancy. Options for fertility preservation and alternatives to TKI therapy should be discussed with all patients.
Amyloidosis: Diagnosis, Treatment, and Supportive Care
  • Systemic Light Chain Amyloidosis
  • 0.50 AAPA Category 1 CME credit
  • 0.50 ACPE contact hours
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 ANCC contact hours
  • 0.50 Participation
$0.00
High rates of early mortality in newly diagnosed systemic light-chain amyloidosis (SLCA) suggest that there continues to be a delay in early diagnosis. The initial evaluation must confirm the diagnosis, establish the extent and sites of disease, and evaluate for comorbidities that are likely to have an impact on prognosis and treatment options. Many of the novel agents used in the treatment of multiple myeloma are being utilized in the treatment of SLCA, and the treatment armamentarium is growing.